They showed that EPO can stimulate both lymph node lymphangiogenesis and nodal metastasis by increased migration, capillary-like tube formation, and dose- and time-dependent proliferation of human lymphatic ECs in tumor-bearing animals. This evidence concerns the gene EPO and neoplasm.